Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $21,287 - $24,705
300 New
300 $23,000
Q1 2024

May 01, 2024

BUY
$65.98 - $77.09 $13,196 - $15,418
200 New
200 $14,000
Q2 2023

Aug 10, 2023

BUY
$73.76 - $85.98 $44,256 - $51,588
600 New
600 $48,000
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $258,136 - $359,720
-800 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $283,080 - $390,232
800 New
800 $346,000
Q4 2021

Feb 11, 2022

SELL
$456.15 - $525.06 $410,535 - $472,553
-900 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $400,383 - $484,992
900 New
900 $436,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.95B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.